Telomere shortening correlates with disease severity in hemoglobin H disease patients

Blood Cells Mol Dis. 2021 Jul:89:102563. doi: 10.1016/j.bcmd.2021.102563. Epub 2021 Mar 26.

Abstract

Hemoglobin H (Hb H) disease is the most significant health problem of the α-thalassemia syndromes. The Hb disease patients are categorized based on their genotype to deletional and nondeletional, with the latter genotype presents the more severe clinical symptoms. Since telomere length is an indicator of biological aging and health, we hypothesized that telomere length could reflect Hb H disease's severity. In this study, we recruited 48 deletional and 47 nondeletional Hb H disease patients, along with 109 normal controls, for telomere length assessment. The leukocyte telomere length was assessed by monochromatic multiplex real-time PCR and reported as the telomere to single-copy gene (T/S) ratio. When telomere length was adjusted for age, the analysis of covariance between the control and the two Hb H disease groups revealed no significant difference. However, the telomere shortening rate was more rapid in the nondeletional Hb H disease group than those of the control and deletional Hb H disease groups. Gender analysis found that male patients have a significantly lower T/S ratio than females in the nondeletional group but not in the control and deletional groups. In the two disease groups, the T/S ratio was not influenced by ferritin level or transfusion burden but was positively correlated with the absolute reticulocyte count.

Keywords: Alpha thalassemia; Hemoglobin H disease; Iron overload; Telomere length.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Blood Transfusion
  • Child
  • Female
  • Ferritins / blood
  • Gene Deletion
  • Hemoglobin H / genetics*
  • Humans
  • Male
  • Middle Aged
  • Severity of Illness Index
  • Telomere Shortening*
  • Young Adult
  • alpha-Thalassemia / blood
  • alpha-Thalassemia / diagnosis
  • alpha-Thalassemia / genetics*
  • alpha-Thalassemia / therapy
  • beta-Globins / genetics*

Substances

  • beta-Globins
  • Ferritins
  • Hemoglobin H